Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study

被引：0

作者：

Lowell L. Hart

Renata Ferrarotto

Zoran G. Andric

J. Thaddeus Beck

Janakiraman Subramanian

Davorin Z. Radosavljevic

Bojan Zaric

Wahid T. Hanna

Raid Aljumaily

Taofeek K. Owonikoko

Didier Verhoeven

Jie Xiao

Shannon R. Morris

Joyce M. Antal

Maen A. Hussein

机构：

[1] Florida Cancer Specialists,Medical Oncology

[2] Wake Forest University School of Medicine,Department of Medicine

[3] University of Texas MD Anderson Cancer Center,Department of Thoracic and Head and Neck Medical Oncology

[4] Clinical Hospital Center Bezanijska Kosa,Medical Oncology Department

[5] Department of Medical Oncology and Hematology,Department of Medicine

[6] Highlands Oncology Group,Faculty of Medicine, Institute for Pulmonary Diseases of Vojvodina

[7] Saint Luke’s Hospital,Hematology/Oncology

[8] Institute for Oncology and Radiology of Serbia,Stephenson Cancer Center

[9] University of Novi Sad,Department of Hematology and Medical Oncology

[10] University of Tennessee Graduate School of Medicine,Department of Medical Oncology, AZ Klina Brasschaat

[11] University of Oklahoma,Department of Oncology

[12] Sarah Cannon Research Institute,undefined

[13] Emory University,undefined

[14] University of Antwerp,undefined

[15] G1 Therapeutics,undefined

[16] Inc.,undefined

[17] Florida Cancer Specialists,undefined

来源：

Advances in Therapy | 2021年 / 38卷

关键词：

Anemia; Chemotherapy; Myelopreservation; Myelosuppression; Neutropenia; Patient-reported outcomes; Small cell lung cancer; Topotecan; Trilaciclib;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：350 / 365

页数：15

共 50 条

[21] SALUTE: a placebo-controlled, double-blind, multicenter, randomized, phase II study of bevacizumab in previously untreated extensive-stage small cell lung cancer (SCLC)
Spigel, David R.
Townley, Peter M.
Waterhouse, David M.
Fang Liang
Adiguzel, Ibrahim
Huang, Jane E.
Scappaticci, Frank A.
Socinski, Mark A.
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S398 - S398
[22] Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy
Saadipoor, Afshin
Razzaghdoust, Abolfazl
Simforoosh, Nasser
Mahdavi, Arash
Bakhshandeh, Mohsen
Moghadam, Maryam
Abdollahi, Hamid
Mofid, Bahram
PHYTOTHERAPY RESEARCH, 2019, 33 (02) : 370 - 378
[23] DAILY ORAL PERIFOSINE IN COMBINATION WITH RADIOTHERAPY IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER: FIRST RESULTS OF A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER PHASE II STUDY
Verheij, M.
Karchmit, Y.
Bakardjiev, S.
Beliaukouski, V.
Savu, M.
Smickoska, S.
Sindermann, H.
Markivskyy, A.
RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S167 - S167
[24] Ondansetron in patients with tinnitus: randomized double-blind placebo-controlled study
Taslimi, Shervin
Vahidi, Hamed
Pourvaziri, Ali
Modabbernia, Amirhossein
Fallah, Arezoo Yeke
Yazdani, Nasrin
Taslimi, Negin
Hosseini, Mostafa
Zarandi, Masoud Motesadi
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2013, 270 (05) : 1635 - 1641
[25] A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis
Howard, James F., Jr.
Barohn, Richard J.
Cutter, Gary R.
Freimer, Miriam
Juel, Vern C.
Mozaffar, Tahseen
Mellion, Michelle L.
Benatar, Michael G.
Farrugia, Maria Elena
Wang, Jing Jing
Malhotra, Suneil S.
Kissel, John T.
MUSCLE & NERVE, 2013, 48 (01) : 76 - 84
[26] A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy
Giles, FJ
Rodriguez, R
Weisdorf, D
Wingard, JR
Martin, PJ
Fleming, TR
Goldberg, SL
Anaissie, EJ
Bolwell, BJ
Chao, NJ
Shea, TC
Brunvand, MM
Vaughan, W
Petersen, F
Schubert, M
Lazarus, HM
Maziarz, RT
Silverman, M
Beveridge, RA
Redman, R
Pulliam, JG
Devitt-Risse, P
Fuchs, HJ
Hurd, DD
LEUKEMIA RESEARCH, 2004, 28 (06) : 559 - 565
[27] A randomized, double-blind, placebo-controlled phase II study of ularitide in patients with decompensated congestive heart failure
Mitrovic, V
Seferovic, P
Simeunovic, D
Miric, M
Moiseyev, VS
Kobalava, Z
Nitsche, K
Forssmann, WG
Luss, H
Meyer, M
JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : S151 - S151
[28] Ondansetron in patients with tinnitus: randomized double-blind placebo-controlled study
Shervin Taslimi
Hamed Vahidi
Ali Pourvaziri
Amirhossein Modabbernia
Arezoo Yeke Fallah
Nasrin Yazdani
Negin Taslimi
Mostafa Hosseini
Masoud Motesadi Zarandi
European Archives of Oto-Rhino-Laryngology, 2013, 270 : 1635 - 1641
[29] A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer - The FALUCA study
Lu, Shun
Chen, Gongyan
Sun, Yuping
Sun, Sanyuan
Chang, Jianhua
Yao, Yu
Chen, Zhendong
Ye, Feng
Lu, Junguo
Shi, Jianhua
He, Jianxing
Liu, Xiaoqing
Zhang, Yiping
Liu, Zhihua
Fang, Jian
Cheng, Ying
Hu, Chunhong
Mao, Weidong
Hu, Yanping
Gong, Youling
Shan, Li
Yang, Zhixiong
Song, Yong
Li, Wei
Bai, Chong
Wang, Buhai
Ma, Rui
Zheng, Zhendong
Liu, Mingfang
Jie, Zhijun
Cao, Lejie
Liao, Wangjun
Pan, Hongming
Huang, Dongning
Chen, Yuan
Yang, Jinji
Qin, Shukui
Ma, Shenglin
Liang, Li
Liu, Zhe
Zhou, Jianying
Tao, Min
Huang, Yijiang
Qiu, Feng
Huang, Yunchao
Guan, Sha
Peng, Mengye
Su, Weiguo
LUNG CANCER, 2020, 146 : 252 - 262
[30] Vitamin D Supplementation and Survival of Patients with Non-small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
Akiba, Tadashi
Morikawa, Toshiaki
Odaka, Makoto
Nakada, Takeo
Kamiya, Noriki
Yamashita, Makoto
Yabe, Mitsuo
Inagaki, Takuya
Asano, Hisatoshi
Mori, Shohei
Tsukamoto, Yo
Urashima, Mitsuyoshi
CLINICAL CANCER RESEARCH, 2018, 24 (17) : 4089 - 4097

← 1 2 3 4 5 →